BioCentury
ARTICLE | Financial News

Obesity play Zafgen secures $45 million in series E

December 5, 2013 1:55 AM UTC

Zafgen Inc. (Cambridge, Mass.) raised $35 million in the first tranche of a $45 million series E round from new investors RA Capital Management; Brookside Capital; Venrock; an undisclosed blue chip in...